Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Efficacy and Safety of TP-06 for PCED
Sponsor: Tarsus Pharmaceuticals, Inc.
Summary
Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.
Official title: A Multicenter, Randomized, Double-Masked, Vehicle Controlled Study to Assess the Efficacy and Safety of TP-06 in Participants With Persistent Corneal Epithelial Defects
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2026-04-20
Completion Date
2028-07-07
Last Updated
2026-10-21
Healthy Volunteers
No
Conditions
Interventions
TP-06
TP-06 ophthalmic solution
Vehicle of TP-06
Vehicle of TP-06 ophthalmic solution
Locations (14)
Tarsus Investigative Site
Scottsdale, Arizona, United States
Tarsus Investigative Site
Tampa, Florida, United States
Tarsus Investigative Site
Atlanta, Georgia, United States
Tarsus Investigative Site
Alexandria, Minnesota, United States
Tarsus Investigative Site
Dover, New Jersey, United States
Tarsus Investigative Site
Palisades Park, New Jersey, United States
Tarsus Investigative Site
Babylon, New York, United States
Tarsus Investigative Site
Mt. Pleasant, South Carolina, United States
Tarsus Investigative Site
Houston, Texas, United States
Tarsus Investigative Site
Sugar Land, Texas, United States
Tarsus Investigative Site
Santo Domingo, Dominican Republic
Tarsus Investigative Site
San Salvador, El Salvador
Tarsus Investigative Site
Mexico City, Mexico
Tarsus Investigative Site
Monterrey, Mexico